Transplantation Tumor Heterologous

Heterologous tumor transplantation (tumoris heterologica) is a surgical procedure of transplanting viable tumor tissue from one patient to another for the purpose of treating a tumor disease or alleviating some forms of Down syndrome and Shereshevsky-Turner syndrome. Transplantation was first used at the beginning of the 20th century in the treatment of aplastic anemia.

Transplanting tissues called heterologous material, meaning "derived from another organism," may be the first most spectacular way to show how gene transplantation works. These experiments not only create living tissues, but also give control over their genetic code. In short, they are the leading representatives of the coming era of artificial intelligence. By using the genes of a wide variety of creatures - such as frogs, caterpillars and fungi - biotech engineers are able to make them divide and reproduce at the cellular level at will.

Even if you are already fairly knowledgeable about the organ transplant process, tumor tissue transplantation may still seem daunting. But it's actually not that bad. If you are alone

Heterologous tumor transplantation (or heterotransplantation) is one of the methods of treating oncological diseases, based on the introduction of tumors from other people or animals into the patient’s body. It is used in cases where the patient’s own tumor cannot be used to influence cancer cells, and classical surgery methods cannot bring the desired result. Transplanted cancer tissues contain